Home › Targets › TL1A
TL1A (3 companies · 12 programs)
Companies with an active program directed at TL1A.
- SPY002 — Ulcerative Colitis Phase 2
- SPY002 — Crohn's Disease Phase 2
- SPY072 — Rheumatoid Arthritis Phase 2
- SPY072 — Psoriatic Arthritis Phase 2
- SPY072 — Axial Spondyloarthritis Phase 2
- SPY120 — Ulcerative Colitis Phase 2
- SPY230 — Ulcerative Colitis Phase 2
- XmAb942 — Ulcerative Colitis Phase 2
- XmAb942 — Crohn's Disease Phase 1
- XmAb412 — Crohn's Disease Preclinical
- XmAb412 — Ulcerative Colitis Preclinical
- ABS-101 — Inflammatory Bowel Disease Phase 1
